ASEPTIKA LIMITED

Asthma+me App, an integrated Class 1 Medical Device for paediatric asthma self-care.

Asthma+me solution: moderate-severe paediatric asthma

Asthma+me has been designed to support the whole family in learning about the severity of your child’s asthma, how to manage it and provide the tools for both parents and the Paediatricians to monitor the level of control being achieved between appointments and at home.
Designed to support the whole family in learning about asthma, how to manage it, connected devices to track your asthma data using the subscription Asthma+me App for iOS, Android and Amazon devices.
PUFFClicker Smart tracker for pressurised metered-dose inhalers (pMDIs).

Learn together as a family about asthma, encourage medication adherence and behaviour change to get your asthma under control with self-care.
Interactive care plan, comprehensive graphing, summaries and report generation of all your data for you and your healthcare team and for inclusion in your medical records.

https://www.activ8rlives.com/stories/taking-control-of-asthma-ready-for-gcses/

PUFFClicker smart pMD Inhaler tracker as part of the Asthma+me solution for paediatric asthma self-care solultion

PUFFClicker Smart pMD Inhaler tracker for all the common inhalers children prescribed for medication adherance

Company details

Incorporated:
13 November 2007
Industry:
Healthcare and medical
“Sheffield Children’s Hospital is treating an increasing number of children with moderate-to-severe asthma who need to take time-off from school with their parents, to travel for up to 2 hours to attend our outpatient clinics here. It is essential that the waiting times for their first outpatient appointment is as short as possible which means that we must free the time of front-line staff where ever we can. We are always looking for innovative ways to deploy new technologies to improve the quality of our care, work with more patients and achieve this as efficiently as possible. SBRI Healthcare has provided the opportunity to work directly with Aseptika to co-develop a solution as a possible alternative to outpatient appointments, building skills and good management techniques which will stay with them when they reach 18 years of age and transfer to adult services.”
Professor Heather Elphick Consultant in Paediatric Respiratory Medicine and is the Lead for Children and Young People’s National Institute of Healthcare Research Medtech and In vitro diagnostic Co-operative Sheffield Children’s Hospital NHS Foundation Trust